Deal Library / Pharma BD Deal Intelligence

Vertex Pharmaceuticals Incorporated — Pharma Deals

The Pharma Closeout tracks 7 deals, $14.8B in disclosed deal value, 3 with a post-close Outcome Score for Vertex Pharmaceuticals Incorporated.

Median Critic Score: 82  ·  Median Outcome Score: 85

Best outcome: Vertex Pharmaceuticals Incorporated / Aurora Biosciences Corporation (95)  ·  Weakest outcome: Vertex Pharmaceuticals Incorporated / Crinetics Pharmaceuticals, Inc. (68)

All 7 deals

• Vertex Pharmaceuticals Incorporated / Aurora Biosciences Corporation — 2001 · $592M · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Concert Pharmaceuticals, Inc. — 2017 · $250M · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Crinetics Pharmaceuticals, Inc. — 2026 · $10.0B · Largely worked — most objectives met.
• Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2023 · $330M
• Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2021 · $1.1B
• Vertex Pharmaceuticals Incorporated / Exonics Therapeutics, Inc. — 2019 · $1.0B
• Vertex Pharmaceuticals Incorporated / Alios BioPharma, Inc. — 2011 · $1.5B

← Deal Library  ·  Interactive search  ·  How we score deals